03_RFB 26200957-1_BRAND NAME ONLY - SIGMA-ALDRICH_CERILLIANT - DRUG STANDARDS, CONTROLS, AND REAGENTS_.pdf

PDF 141 B Posted

Attached to
26-0534 BRAND ONLY_Sigma-Aldrich/Cerilliant_BID DUE 6-2-2026
Solicitation number
RFB-IS-26200957
Issued by
California

About this file

This is a Request for Bids (RFB) document issued by the State of California for the procurement of brand name only Sigma-Aldrich/Cerilliant drug standards, controls, and reagents under contract opportunity 26-0534 (RFB 26200957-1). The solicitation seeks comprehensive unit pricing for multiple line items and quantities of specified Sigma-Aldrich and Cerilliant products designated for forensic and laboratory-grade reference materials used in pharmaceutical testing, drug analysis, and quality control applications within California's laboratory testing protocols. The procurement was posted on May 11, 2026, with bids due by June 2, 2026, providing interested vendors a sixteen-day response window to prepare and submit proposals. No site visits or bidders' conferences are noted in the available documentation, and no specific award dates or contract term information is provided in the solicitation materials.

The procurement is restricted to products manufactured exclusively by Sigma-Aldrich/Cerilliant, with no consideration of equivalent alternative products permitted, reflecting the state's determination that these specific products are essential for laboratory operations and compatibility with existing protocols and equipment. The solicitation includes set-aside provisions for certified business enterprises, requiring all bidders to submit mandatory forms including a Certified Business Enterprise (CBE) Form and a HIPAA Business Associate Agreement (BAA) Contractor Acknowledgement confirming compliance with federal privacy and security regulations regarding protected health information. No incumbent vendors, specific award values, or budget ranges are identified in the available solicitation documents. The brand name only designation and HIPAA requirements indicate that the successful contractor will handle sensitive health information and must implement appropriate safeguards throughout the contract term.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

/tmp/127963204-0036700001780314482/03_RFB 26200957-1_BRAND NAME ONLY - SIGMA-ALDRICH_CERILLIANT - DRUG STANDARDS, CONTROLS, AND REAGENTS_.pdf

File details come from the government source that posted it. Updated .